| T-BSDB-H209 |
Recombinant Human Anti-CD16 x Anti-CD30 Bispecific Antibody (Tandem Diabody) |
Human |
|
CD16 |
CD30 |
Inquiry |
| T-BSDB-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Tandem Diabody) |
Human |
|
CD16 |
CD30 |
Inquiry |
| SCIGG-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (scIgG) |
Human |
Single chain IgGs |
CD16 |
CD30 |
Inquiry |
| SCIGG-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (scIgG) |
Human |
Single chain IgGs |
CD16 |
CD30 |
Inquiry |
| FVTIG-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (scFv4-Ig) |
Human |
Appended IgGs |
CD16 |
CD30 |
Inquiry |
| FVTIG-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (scFv4-Ig) |
Human |
Appended IgGs |
CD16 |
CD30 |
Inquiry |
| BSSG-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (scFv-IgG) |
Human |
Appended IgGs |
CD16 |
CD30 |
Inquiry |
| BSSG-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (scFv-IgG) |
Human |
Appended IgGs |
CD16 |
CD30 |
Inquiry |
| IGLFV-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (IgG(L)-scFv) |
Human |
Appended IgGs |
CD16 |
CD30 |
Inquiry |
| IGLFV-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (IgG(L)-scFv) |
Human |
Appended IgGs |
CD16 |
CD30 |
Inquiry |
| BSGV-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (IgG-Fv) |
Human |
IgG-Fv |
CD16 |
CD30 |
Inquiry |
| BSGV-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (IgG-Fv) |
Human |
IgG-Fv |
CD16 |
CD30 |
Inquiry |
| BSDG-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (Fv-IgG) |
Human |
Appended IgGs |
CD16 |
CD30 |
Inquiry |
| BSDG-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Fv-IgG) |
Human |
Appended IgGs |
CD16 |
CD30 |
Inquiry |
| BABFV-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (F(ab')2-scFv2) |
Human |
Fab-Fc Fusion Proteins |
CD16 |
CD30 |
Inquiry |
| BABFV-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (F(ab')2-scFv2) |
Human |
Fab-Fc Fusion Proteins |
CD16 |
CD30 |
Inquiry |
| FABVC-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (Fab-scFv-Fc) |
Human |
Fab-Fc Fusion Proteins |
CD16 |
CD30 |
Inquiry |
| FABVC-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Fab-scFv-Fc) |
Human |
Fab-Fc Fusion Proteins |
CD16 |
CD30 |
Inquiry |
| SCDBC-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (scDiabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| SCDBC-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (scDiabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSDBC-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (Diabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSDBC-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Diabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| SCDBF-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (scDiabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| SCDBF-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (scDiabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSFVF-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (Tandem scFv-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSFVF-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Tandem scFv-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSDBF-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (Diabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSDBF-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Diabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSTF-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (scFv-Fc-scFv) |
Human |
scFv-based Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSTF-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (scFv-Fc-scFv) |
Human |
scFv-based Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSCFV-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (scFv-Fc) |
Human |
scFv-based Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSCFV-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (scFv-Fc) |
Human |
scFv-based Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| MNAB-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (Miniantibody) |
Human |
scFv-based Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| MNAB-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Miniantibody) |
Human |
scFv-based Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSFC-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (scFv-CH3) |
Human |
scFv-based Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSFC-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (scFv-CH3) |
Human |
scFv-based Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSCC-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (scFv-CH1/CL) |
Human |
scFv-based Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BSCC-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (scFv-CH1/CL) |
Human |
scFv-based Bispecific Fragments |
CD16 |
CD30 |
Inquiry |
| BIBD-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (Bibody) |
Human |
Bibody |
CD16 |
CD30 |
Inquiry |
| BIBD-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Bibody) |
Human |
Bibody |
CD16 |
CD30 |
Inquiry |
| FABFV-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (Fab-Fv) |
Human |
Fab-Fv |
CD16 |
CD30 |
Inquiry |
| FABFV-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Fab-Fv) |
Human |
Fab-Fv |
CD16 |
CD30 |
Inquiry |
| MiniB-H211 |
Recombinant Human Anti-CD16 x Human Anti-CD30 Bispecific Antibody (Minibody) |
Human |
Minibody |
CD16 |
CD30 |
Inquiry |
| MiniB-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Minibody) |
Human |
Minibody |
CD16 |
CD30 |
Inquiry |
| SCTB-H111 |
Recombinant Human Anti-CD30 x Human Anti-CD16 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD16 |
CD30 |
Inquiry |
| SCDB-H209 |
Recombinant Human Anti-CD16 x Anti-CD30 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD16 |
CD30 |
Inquiry |
| FABIG-H209 |
Recombinant Human Anti-CD16 x Anti-CD30 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
CD30 |
Inquiry |
| TRIB-H211 |
Recombinant Human Anti-CD16 x Anti-CD30 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
CD30 |
Inquiry |
| BSIG-H209 |
Human Anti-CD16 x Anti-CD30 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
CD30 |
Inquiry |
| CROSSAB-H209 |
Recombinant Human Anti-CD16 x Anti-CD30 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
CD30 |
Inquiry |
| IGFV-H209 |
Recombinant Human Anti-CD16 x Anti-CD30 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
CD30 |
Inquiry |
| BSDB-H209 |
Recombinant Human Anti-CD16 x Anti-CD30 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
CD30 |
Inquiry |
| BSFAB-H209 |
Recombinant Human Anti-CD16 x Anti-CD30 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
CD30 |
Inquiry |
| BSFV-H209 |
Recombinant Human Anti-CD16 x Anti-CD30 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
CD30 |
Inquiry |
| SCTB-011 |
Recombinant Anti-CD30 x Anti-CD16 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD16 |
CD30 |
Inquiry |
| SCDB-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD16 |
CD30 |
Inquiry |
| FABIG-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
CD30 |
Inquiry |
| TRIB-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
CD30 |
Inquiry |
| BSIG-034 |
Anti-CD16 x Anti-CD30 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
CD30 |
Inquiry |
| CROSSAB-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
CD30 |
Inquiry |
| IGFV-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
CD30 |
Inquiry |
| BSDB-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
CD30 |
Inquiry |
| BSFAB-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
CD30 |
Inquiry |
| BSFV-034 |
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
CD30 |
Inquiry |
| SCTB-084 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD317 |
CD16 |
Inquiry |
| SCTB-083 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD30 |
CD64 |
Inquiry |
| SCTB-037 |
Recombinant Anti-CD30 x Anti-CD3 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD3 |
CD30 |
Inquiry |
| SCTB-027 |
Recombinant Anti-CD30 x Anti-CD28 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD28 |
CD30 |
Inquiry |
| SCTB-014 |
Recombinant Anti-HER2 x Anti-CD16 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD16 |
HER2 |
Inquiry |
| SCTB-013 |
Recombinant Anti-GD2 x Anti-CD16 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD16 |
GD2 |
Inquiry |
| SCTB-012 |
Recombinant Anti-EGFR x Anti-CD16 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD16 |
EGFR |
Inquiry |
| SCDB-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD33 |
CD16 |
Inquiry |
| SCDB-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD317 |
CD16 |
Inquiry |
| SCDB-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD30 |
CD64 |
Inquiry |
| SCDB-065 |
Recombinant Anti-CD3 x Anti-CD30 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD3 |
CD30 |
Inquiry |
| SCDB-055 |
Recombinant Anti-CD28 x Anti-CD30 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD28 |
CD30 |
Inquiry |
| SCDB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD16 |
HER2 |
Inquiry |
| SCDB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD16 |
GD2 |
Inquiry |
| SCDB-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD16 |
EGFR |
Inquiry |
| SCDB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD16 |
CD32B |
Inquiry |
| FABIG-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD33 |
CD16 |
Inquiry |
| FABIG-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD317 |
CD16 |
Inquiry |
| FABIG-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD30 |
CD64 |
Inquiry |
| FABIG-065 |
Recombinant Anti-CD3 x Anti-CD30 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD3 |
CD30 |
Inquiry |
| FABIG-055 |
Recombinant Anti-CD28 x Anti-CD30 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD28 |
CD30 |
Inquiry |
| FABIG-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
HER2 |
Inquiry |
| FABIG-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
GD2 |
Inquiry |
| FABIG-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
EGFR |
Inquiry |
| FABIG-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD16 |
CD32B |
Inquiry |
| TRIB-193 |
Recombinant Anti-CD16 x Anti-CD33 x Anti-CD19 Trispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
CD33 |
Inquiry |
| TRIB-192 |
Recombinant Anti-CD16 x Anti-CD33 x Anti-CD123 Trispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
CD33 |
Inquiry |
| TRIB-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD33 |
CD16 |
Inquiry |
| TRIB-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD317 |
CD16 |
Inquiry |
| TRIB-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD30 |
CD64 |
Inquiry |
| TRIB-065 |
Recombinant Anti-CD3 x Anti-CD30 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD3 |
CD30 |
Inquiry |
| TRIB-055 |
Recombinant Anti-CD28 x Anti-CD30 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD28 |
CD30 |
Inquiry |
| TRIB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
HER2 |
Inquiry |
| TRIB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
GD2 |
Inquiry |
| TRIB-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
EGFR |
Inquiry |
| TRIB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD16 |
CD32B |
Inquiry |
| BSIG-114 |
Anti-CD33 x Anti-CD16 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD33 |
CD16 |
Inquiry |
| BSIG-111 |
Anti-CD317 x Anti-CD16 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD317 |
CD16 |
Inquiry |
| BSIG-110 |
Anti-CD30 x Anti-CD64 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD30 |
CD64 |
Inquiry |
| BSIG-065 |
Anti-CD3 x Anti-CD30 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD3 |
CD30 |
Inquiry |
| BSIG-055 |
Anti-CD28 x Anti-CD30 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD28 |
CD30 |
Inquiry |
| BSIG-038 |
Anti-CD16 x Anti-HER2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
HER2 |
Inquiry |
| BSIG-037 |
Anti-CD16 x Anti-GD2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
GD2 |
Inquiry |
| BSIG-036 |
Anti-CD16 x Anti-EGFR Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
EGFR |
Inquiry |
| BSIG-035 |
Anti-CD16 x Anti-CD32B Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD16 |
CD32B |
Inquiry |
| CROSSAB-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD33 |
CD16 |
Inquiry |
| CROSSAB-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD317 |
CD16 |
Inquiry |
| CROSSAB-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD30 |
CD64 |
Inquiry |
| CROSSAB-065 |
Recombinant Anti-CD3 x Anti-CD30 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD3 |
CD30 |
Inquiry |
| CROSSAB-055 |
Recombinant Anti-CD28 x Anti-CD30 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD28 |
CD30 |
Inquiry |
| CROSSAB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
HER2 |
Inquiry |
| CROSSAB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
GD2 |
Inquiry |
| CROSSAB-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
EGFR |
Inquiry |
| CROSSAB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
CD32B |
Inquiry |
| IGFV-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD33 |
CD16 |
Inquiry |
| IGFV-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD317 |
CD16 |
Inquiry |
| IGFV-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD30 |
CD64 |
Inquiry |
| IGFV-065 |
Recombinant Anti-CD3 x Anti-CD30 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD3 |
CD30 |
Inquiry |
| IGFV-055 |
Recombinant Anti-CD28 x Anti-CD30 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD28 |
CD30 |
Inquiry |
| IGFV-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
HER2 |
Inquiry |
| IGFV-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
GD2 |
Inquiry |
| IGFV-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
EGFR |
Inquiry |
| IGFV-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
CD32B |
Inquiry |
| BSDB-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD33 |
CD16 |
Inquiry |
| BSDB-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD317 |
CD16 |
Inquiry |
| BSDB-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD30 |
CD64 |
Inquiry |
| BSDB-065 |
Recombinant Anti-CD3 x Anti-CD30 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD3 |
CD30 |
Inquiry |
| BSDB-055 |
Recombinant Anti-CD28 x Anti-CD30 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD28 |
CD30 |
Inquiry |
| BSDB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
HER2 |
Inquiry |
| BSDB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
GD2 |
Inquiry |
| BSDB-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
EGFR |
Inquiry |
| BSDB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
CD32B |
Inquiry |
| BSFAB-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD33 |
CD16 |
Inquiry |
| BSFAB-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD317 |
CD16 |
Inquiry |
| BSFAB-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD30 |
CD64 |
Inquiry |
| BSFAB-065 |
Recombinant Anti-CD3 x Anti-CD30 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD3 |
CD30 |
Inquiry |
| BSFAB-055 |
Recombinant Anti-CD28 x Anti-CD30 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD28 |
CD30 |
Inquiry |
| BSFAB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
HER2 |
Inquiry |
| BSFAB-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
GD2 |
Inquiry |
| BSFAB-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
EGFR |
Inquiry |
| BSFAB-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
CD32B |
Inquiry |
| BSFV-114 |
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD33 |
CD16 |
Inquiry |
| BSFV-111 |
Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD317 |
CD16 |
Inquiry |
| BSFV-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD30 |
CD64 |
Inquiry |
| BSFV-065 |
Recombinant Anti-CD3 x Anti-CD30 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD3 |
CD30 |
Inquiry |
| BSFV-055 |
Recombinant Anti-CD28 x Anti-CD30 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD28 |
CD30 |
Inquiry |
| BSFV-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
HER2 |
Inquiry |
| BSFV-037 |
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
GD2 |
Inquiry |
| BSFV-036 |
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
EGFR |
Inquiry |
| BSFV-035 |
Recombinant Anti-CD16 x Anti-CD32B Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
CD32B |
Inquiry |
Fig.1 Schematic depiction of tumor cell eradication by innate immune cells via CD16/CD30 bispecific antibody.1
